Researchers discover bacteriophage ‘Muddy’ and antibiotic rifabutin as a new dynamic duo combination therapy against antibiotic-resistant Mycobacterium abscessus infection in a cystic fibrosis zebrafish…
Eight strains of azole-resistant Aspergillus fumigatus (A. fumigatus) – a pathogenic fungus that infects humans – have…
Candida auris is a fungus often found in the hospital environment that can cause life-threatening…
World Antimicrobial Awareness Week 2020 (WAAW; 18–24 November) is upon us. Infectious Diseases Hub takes…
In this podcast, Juandem Agendia and Sarah Alexander (NCTC, UK) discuss bacteriophages, the function of…
Phages are a promising alternative to antibiotics, especially considering the looming increase in multidrug-resistant bacteria.…
Exploring the evidence to support the role of home and community hygiene in preventing the…
Bacteriophages (viruses that invade bacteria and can kill them) have gained renewed interest as part…
Rebiotix (MN, USA) recently announced positive preliminary results from an ongoing clinical trial investigating the use of an investigational microbiota-based formulation, RBX2660, for the reduction of C. diff infection.
Researchers from Princeton University have uncovered an antibiotic molecule capable of killing both Gram-negative and Gram-positive bacteria using two simultaneous mechanisms, while also avoiding antibiotic resistance.
